Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/20/2003WO2003023408A1 Compositions and methods for aa4rp assay
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023041A2 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
03/20/2003WO2003023025A1 Multiplication of viruses in a cell culture
03/20/2003WO2003023023A1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
03/20/2003WO2003023021A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022886A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022881A2 Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022879A2 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
03/20/2003WO2003022878A2 Subunit respiratory syncytial virus vaccine preparation
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022868A2 Metal binding proteins and associated methods
03/20/2003WO2003022867A2 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022307A1 Attenuated bacteria useful in vaccines
03/20/2003WO2003022306A2 Bacterial vaccine
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022282A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/20/2003WO2003006055A8 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
03/20/2003WO2002101412A3 Spray freeze-dried compositions
03/20/2003WO2002100836A8 Compounds, compositions and methods for modulating beta-amyloid production
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002094342A3 Compositions for protein delivery via the pulmonary route
03/20/2003WO2002092786A3 A helper dependent adenoviral vector system and methods for using the same
03/20/2003WO2002092131A3 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002072142A3 Modulation of a balance between the gut mucosal immune system and the intestinal microflora
03/20/2003WO2002069908A3 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
03/20/2003WO2002058635A3 Nicotine immunogens and antibodies and uses thereof
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002034882A3 Genes regulating programmed cell death
03/20/2003WO2002028427A3 Pharmaceutical composition for immunisation against aids
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2001085219A3 Identification, diagnosis, and treatment of breast cancer
03/20/2003WO2001070253A8 Use of mia in immunotherapy
03/20/2003US20030056233 Induction of psoriasis in animal model; obtain cells, transfer to transgenic rodent, administer cytokine, monitor development of skin disorder
03/20/2003US20030055307 Devices for detection and therapy of atheromatous plaque
03/20/2003US20030055224 Antibody for use in the treatment of tumor disorders
03/20/2003US20030055223 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
03/20/2003US20030055220 Protein complex for use in the diagnosis and prevention of bacterial infections
03/20/2003US20030055217 Peptides derived from STEAP1
03/20/2003US20030055216 Nucleotide sequences coding polypeptide for use in the treatment of tumors
03/20/2003US20030055019 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030054994 Apoptosis inducing proteinaceous substance
03/20/2003US20030054993 For contraception in a mammal, for therapy of infertility
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054986 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054505 Infectious Respiratory Syncytial Viral particle for use as gene transfer tool in genetic engineering
03/20/2003US20030054493 Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease
03/20/2003US20030054488 Goodpasture antigen binding protein
03/20/2003US20030054446 Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
03/20/2003US20030054436 Staphylococcus aureus polynucleotides and sequences
03/20/2003US20030054421 Nucleotide sequences coding polypeptide for use in the treatment of cancer
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054406 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054405 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054390 Oligonucleotide mediated nucleic acid recombination
03/20/2003US20030054382 Infection of eukaryotic cells with viruses in vitro
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054337 Malaria immunogen and vaccine
03/20/2003US20030054016 Methods and vaccines for providing in OVO protection against turkey rhinotracheitis
03/20/2003US20030054013 Tuberculosis therapy; anticancer agents
03/20/2003US20030054012 Inducing immunology response; administering to mucous membrane
03/20/2003US20030054011 Anticancer agents
03/20/2003US20030054010 Molecular antigen array
03/20/2003US20030054009 Vaccine; inducing immunology response
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030054003 Antitumor agents, anticarcinogenic agents
03/20/2003US20030054002 Screening, therapy for autoimmune disease
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053987 Synthetic hepatitis c genes
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003US20030053983 Colloidal metal compositions and methods
03/20/2003US20030051736 Method and apparatus using IDSTM for multi-agent therapy
03/20/2003CA2462574A1 Subunit respiratory syncytial virus vaccine preparation
03/20/2003CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460025A1 Attenuated bacteria useful in vaccines
03/20/2003CA2459947A1 Compositions and methods for aa4rp assay
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459769A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
1 ... 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 ... 1823